Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas
Open Access
- 11 November 2019
- journal article
- Published by Heighten Science Publications Corporation in Journal of Neuroscience and Neurological Disorders
- Vol. 3 (2), 162-166
- https://doi.org/10.29328/journal.jnnd.1001027
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Review on intermediate filaments of the nervous system and their pathological alterationsHistochemistry and Cell Biology, 2013
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomasBrain Tumor Pathology, 2012
- Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wallCancer Cell International, 2012
- Low-grade gliomas in adultsJournal of Neurosurgery, 2011
- Comparative Characterization of the Human and Mouse Third Ventricle Germinal ZonesJournal of Neuropathology and Experimental Neurology, 2011
- Nestin in gastrointestinal and other cancers: Effects on cells and tumor angiogenesisWorld Journal of Gastroenterology, 2011
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patientsJournal of Experimental & Clinical Cancer Research, 2008
- The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology GroupRadiation Oncology, 2008
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma GrowthCancer Research, 2008
- Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survivalSurgical Neurology, 2007